Renuva® Volume Restoration in Mason, Ohio
Regenerative Aesthetics offers Renuva® in Mason, Ohio for patients seeking a regenerative approach to selected areas of volume loss and soft-tissue contour change.
Renuva® is an injectable allograft adipose matrix made from donated human adipose tissue. Unlike a traditional hyaluronic acid dermal filler, Renuva provides an extracellular matrix framework designed to support cellular repopulation and vascularization in areas where native fat normally exists.
Over time, the Renuva matrix is remodeled by the body. The manufacturer reports that this process generally occurs over approximately three to six months as the matrix is gradually replaced by the patient’s own adipose tissue.
Renuva may be considered for selected facial, hand, and body areas affected by age-related volume loss, small contour irregularities, depressed scars, or other appropriate soft-tissue deficits.
Every treatment begins with an individualized assessment of anatomy, existing tissue, medical history, previous procedures, and aesthetic goals.
Regenerative Aesthetics welcomes patients from Mason, Cincinnati, West Chester, Deerfield Township, and surrounding Southwest Ohio communities.
What Is Renuva®?
Renuva® is an allograft adipose matrix produced by MTF Biologics from donated human adipose tissue.
The tissue is processed to preserve the extracellular matrix naturally found in adipose tissue while creating an injectable material that can be placed in areas where native fat normally exists.
Rather than functioning as a conventional synthetic or hyaluronic acid filler, the matrix acts as a temporary structural framework within the treated area.
As the treatment site remodels, the matrix supports cellular repopulation and vascularization. MTF describes the material as gradually being replaced by the patient’s own fat.
Renuva is intended for the replacement of damaged or inadequate adipose tissue matrix and for supplemental support of underlying adipose tissue where native fat would normally be present.
How Does Renuva® Work?
Renuva works differently from a traditional dermal filler.
After the allograft adipose matrix is placed within an appropriate fat-containing area, it provides a three-dimensional extracellular framework within the tissue.
This matrix is designed to support cellular repopulation and the development of blood supply within the treated area.
During the months following treatment, the Renuva matrix is gradually remodeled by the body. According to the manufacturer, this process typically occurs over approximately three to six months.
The goal is gradual restoration of adipose volume rather than simply leaving a permanent injectable material in place.
Because biological remodeling varies between patients, the amount, timing, and persistence of visible improvement cannot be guaranteed.
Cheeks and Midface
Renuva may be considered for selected areas of facial volume loss where subcutaneous fat naturally exists, including appropriate cheek and midface concerns.
Temples
Age-related changes in temporal volume may contribute to a more hollow appearance. Renuva may be considered in appropriately selected fat-containing areas following careful anatomical evaluation.
Nasolabial and Facial Volume Changes
In some patients, changes around facial folds are influenced by loss and redistribution of underlying soft tissue. Restoring selected areas of support may be incorporated into a broader facial rejuvenation plan.
Hands
Loss of subcutaneous volume on the backs of the hands can make veins, tendons, and bony structures appear more prominent. Renuva may be used in appropriate areas to restore selected soft-tissue volume.
Depressed Scars
Selected depressed scars associated with an underlying soft-tissue deficit may be evaluated for Renuva treatment when native fat normally exists in the treatment area.
Liposuction Irregularities
Small contour depressions or irregularities following liposuction may sometimes involve localized loss or uneven distribution of adipose tissue. Renuva may be considered for selected defects following individualized evaluation.
Hip Dips and Small Body Contour Deficiencies
Renuva may be used for selected small-volume contour deficiencies in areas such as hip dips or other body locations where native fat naturally exists.
Cellulite Dimples
In selected patients, Renuva may be incorporated into treatment of localized depressions associated with cellulite when restoration of underlying adipose volume is an appropriate part of the treatment plan.
Renuva is designed only for areas where native adipose tissue normally exists.
It should not be placed in tissues or anatomical locations where native fat is not normally present.
According to the manufacturer’s patient information, Renuva should not be injected into the lips, muscle, or breast tissue.
Treatment location must therefore be selected according to anatomy rather than simply according to the area a patient would like to enlarge.
A consultation is required to determine whether the desired treatment area is appropriate for Renuva.
Regenerative Approach to Volume Restoration
Renuva provides an extracellular adipose matrix designed to support cellular repopulation and vascularization as the treated area remodels.
No Fat-Harvesting Procedure
Unlike traditional autologous fat transfer, Renuva does not require liposuction to harvest fat from another part of the patient's body.
In-Office Treatment
Renuva can be placed during an office-based procedure without the general anesthesia typically associated with surgical fat harvesting.
Gradual Volume Restoration
The treatment is designed to remodel gradually rather than relying only on an immediately visible gel implant. Changes continue as the tissue responds over the following months.
Face, Hands and Body Applications
Renuva can be considered for selected small-volume deficits in multiple anatomical areas as long as native fat normally exists at the treatment site.
Personalized Treatment Planning
The amount of Renuva, injection location, number of sessions, and treatment interval can be individualized according to anatomy, volume loss, previous treatments, and aesthetic goals.
Traditional fat transfer involves removing fat from one area of the patient’s body through liposuction, processing the harvested tissue, and transferring it to another location.
Renuva provides an off-the-shelf adipose matrix and therefore does not require a donor site or liposuction to obtain the patient’s own fat before treatment.
This can make Renuva particularly relevant when a relatively small volume of soft-tissue restoration is desired.
However, Renuva and surgical fat grafting are not interchangeable for every indication.
Large-volume augmentation or concerns requiring surgical correction may be better addressed with another approach.
Your provider will determine which option is appropriate based on the treatment area and amount of volume required.
Renuva® vs. Sculptra®
Renuva and Sculptra® are also fundamentally different treatments.
Sculptra is an injectable poly-L-lactic acid product that stimulates collagen formation over time.
Renuva is an allograft adipose extracellular matrix intended for areas where native adipose tissue exists and is designed to support adipose tissue remodeling.
Because their composition, biological mechanism, treatment areas, and regulatory pathways differ, they should not be described as interchangeable products.
The appropriate choice depends on whether the primary goal involves collagen stimulation, adipose volume restoration, structural support, or another aesthetic concern.
What Happens During a Renuva® Treatment?
Your Renuva appointment begins with an evaluation of the area you would like to treat.
Your provider reviews your anatomy, degree and location of volume loss, medical history, allergies, medications, previous injections or surgery, and aesthetic goals.
Renuva is prepared according to the manufacturer’s instructions and placed into an appropriate fat-containing tissue plane using a needle or cannula.
The amount used depends on the treatment area and individual treatment plan.
Renuva is frequently approached as a staged treatment rather than attempting to completely correct every volume deficit during the first session.
Following treatment, your provider will give you specific aftercare instructions based on the area treated and technique used.
How Many Renuva® Treatments Will I Need?
The number of Renuva treatments varies according to the treatment area, degree of volume loss, amount placed during each session, tissue response, and aesthetic goals.
Some patients may require more than one treatment to gradually build the desired volume.
The manufacturer specifically describes Renuva as commonly being used in more than one staged treatment rather than overcorrecting during the initial session.
Your response should be evaluated over time before deciding whether additional Renuva is appropriate.
When Will I See Renuva® Results?
Some initial volume may be visible following placement, but the biological remodeling process takes longer.
According to Renuva’s manufacturer, the matrix is gradually remodeled over approximately three to six months.
Because the treatment relies on tissue remodeling, changes should be evaluated gradually rather than judged only in the first days following treatment.
Individual results vary based on age, anatomy, tissue characteristics, treatment area, amount used, health factors, and biological response.
How Long Does Renuva® Last?
Renuva itself is gradually remodeled rather than remaining permanently as an injectable matrix.
The manufacturer describes the matrix as ultimately being replaced by the patient’s own adipose tissue.
Once formed, that tissue is expected to behave more like native fat than a temporary injectable gel.
Normal aging, weight changes, hormonal changes, health factors, and individual biology can continue to influence fat volume over time.
Long-term controlled clinical data defining an exact duration for every treatment area remain limited.
Is There Downtime After Renuva®?
Renuva is performed as an in-office injectable procedure and generally does not require surgical recovery associated with fat harvesting.
However, injectable treatment can still cause temporary local reactions.
Swelling, tenderness, redness, bruising, pain, or irritation may occur around the treatment site during the immediate post-treatment period.
The manufacturer’s patient information recommends avoiding vigorous exercise for approximately 24 hours following treatment.
Your provider may give additional instructions depending on the treatment area and technique used.
Renuva Contains Donated Human Tissue
Renuva is produced from donated human adipose tissue and is not a synthetic dermal filler.
Donors undergo medical screening and infectious-disease testing according to applicable tissue-banking requirements.
Severe Allergy History
Renuva is contraindicated in patients with significant allergies manifested by a history of anaphylaxis or severe allergen sensitivity.
Infection Risk
As with other procedures involving human tissue, infection is possible. The manufacturer also states that transmission of infectious disease cannot be completely eliminated despite donor screening and testing.
Temporary Injection-Site Reactions
Possible post-treatment reactions include swelling, tenderness, redness, bruising, pain, irritation, or skin discoloration at the treatment site.
Rare Allergic or Immune Reactions
Allergic reactions, including rare severe reactions, as well as specific or nonspecific immune responses to components of the graft are potential adverse effects.
Appropriate Tissue Selection Matters
Renuva must be placed only in appropriate areas where native adipose tissue normally exists. Tissue with poor vascularity, active infection, or other factors that interfere with healing may not be appropriate for treatment.
Renuva should not be described as an “FDA-approved dermal filler.”
Renuva is a human cell, tissue, and cellular and tissue-based product, or HCT/P, and is regulated in the United States under the FDA framework for human tissue.
This regulatory pathway is different from the premarket approval process used for conventional dermal fillers.
MTF Biologics is an FDA-registered tissue establishment, and donor screening and tissue processing are performed under applicable FDA tissue regulations and tissue-banking standards.
What Does the Clinical Evidence Show?
Published clinical experience with allograft adipose matrix continues to develop.
A 2024 real-world case series described seven selected patients treated by experienced U.S. aesthetic physicians for volume concerns involving areas such as the face and hands.
The reported cases showed maintained or improved soft-tissue volume during short-term follow-up, and no adverse events were reported in the selected cases.
However, this was not a randomized controlled clinical trial. The study included a small number of selected cases, lacked a control group, and the authors specifically noted that longer follow-up is needed to better define durability.
The study also disclosed financial support from MTF Biologics.
For this reason, clinical results should be discussed as individualized outcomes rather than guaranteed percentages or a guaranteed treatment duration.
Why Choose Regenerative Aesthetics for Renuva® in Mason, Ohio?
At Regenerative Aesthetics, Renuva is incorporated into a personalized approach to regenerative aesthetic care rather than treated as a universal replacement for every injectable.
Treatment begins with evaluation of facial or body anatomy, location of adipose volume loss, medical history, previous procedures, allergies, and individual aesthetic goals.
Because our clinic offers several approaches to facial and body rejuvenation, including dermal fillers, regenerative treatments, RF microneedling, laser technology, and skin-quality treatments, we can consider which treatment strategy best matches the individual concern.
Our goal is to restore proportion and soft-tissue support while maintaining natural-looking results and realistic expectations.
Regenerative Aesthetics welcomes patients from Mason, Cincinnati, West Chester, Deerfield Township, and surrounding Southwest Ohio communities.
Frequently Asked Questions About Renuva®
What is Renuva®?
Renuva is an injectable allograft adipose matrix made from donated human adipose tissue. It is designed for use in appropriate areas where native fat naturally exists.
Is Renuva a dermal filler?
Renuva is not a traditional hyaluronic acid dermal filler. It is an adipose extracellular matrix designed to support tissue remodeling and gradual restoration of adipose volume.
Is Renuva made from my own fat?
No. The Renuva matrix is produced from carefully screened donated human adipose tissue. The manufacturer describes the matrix as being gradually remodeled and replaced by the patient's own adipose tissue following treatment.
Does Renuva require liposuction?
No. Unlike traditional autologous fat transfer, Renuva does not require fat harvesting or liposuction before treatment.
Where can Renuva be used?
Renuva may be used in appropriate areas where native fat naturally exists. Potential treatment areas include selected regions of the face, hands, depressed scars, liposuction irregularities, hip dips, and other small-volume soft-tissue deficits.
Can Renuva be injected into the lips?
No. Manufacturer guidance states that Renuva should not be injected into the lips.
Can Renuva be injected into muscle?
No. Renuva is intended for appropriate adipose tissue locations and should not be injected into muscle.
How quickly will I see results?
Some volume may be apparent initially, but the remodeling process is gradual. The manufacturer describes the Renuva matrix as remodeling over approximately three to six months.
How long does Renuva last?
Renuva itself is gradually remodeled. The resulting adipose tissue may provide longer-term volume, but duration varies with aging, weight changes, anatomy, treatment area, and individual biology. A specific number of years cannot be guaranteed.
How many Renuva treatments will I need?
Some patients may benefit from more than one staged treatment. The number of sessions depends on the area being treated, degree of volume loss, treatment response, and aesthetic goals.
Is there downtime after Renuva?
Most patients can return to normal daily activities relatively quickly, but temporary swelling, bruising, tenderness, redness, pain, or irritation may occur. Vigorous exercise is generally avoided for approximately 24 hours according to manufacturer guidance.
Is Renuva FDA-approved?
Renuva is not an FDA-approved dermal filler. It is regulated in the United States as a human cell, tissue, and cellular and tissue-based product, or HCT/P, under FDA human-tissue regulations.
Is Renuva right for everyone?
No. Treatment depends on anatomy, medical history, allergy history, condition of the treatment site, and individual goals. Renuva is contraindicated in patients with significant allergies characterized by anaphylaxis or severe allergen sensitivity.
Schedule a Renuva® Consultation in Mason, Ohio
If you are interested in restoring selected areas of facial, hand, or body volume without undergoing traditional fat harvesting, schedule a Renuva® consultation at Regenerative Aesthetics in Mason, Ohio.
Our team will evaluate the location and degree of volume loss, anatomy, medical history, previous aesthetic treatments, allergies, and individual goals to determine whether Renuva or another volume-restoration option may be appropriate.
Regenerative Aesthetics
969 Reading Rd N
Mason, OH 45040
Phone: (513) 204-4483
Email: contact@regenspa.org